伽玛刀放射外科治疗低级别胶质瘤:肿瘤控制与患者生活质量的长期随访临床结果
本研究评估伽玛刀放射外科(GKRS)治疗低级别胶质瘤(LGG)的疗效与安全性,2001至2014年间对39例患者实施42次治疗,平均随访60.5个月;1年、5年、10年无进展生存率分别为74.9%、52.8%、39.1%,实体肿瘤控制率69.2%,52.4%患者临床改善,结论认为GKRS安全有效。
要点
- 1年、5年、10年无进展生存率分别为74.9%、52.8%、39.1%。
- 实体肿瘤控制率69.2%,囊性增大发生率12.9%。
- 52.4%患者临床改善,36项简表健康调查各域平均分与健康意大利人群无显著差异。
核心结论
- 本研究证实GKRS治疗LGG在控制肿瘤生长方面安全有效,并显著改善患者总生存和无进展生存。
- GKRS改善了患者的功能状态和生活质量,优化了社会功能并减少了疾病相关心理影响。
研究设计与样本
- 2001年至2014年间,对39例携带低级别胶质瘤的患者实施了42次伽玛刀放射外科治疗。
- 48%的患者既往接受过手术,20.5%的患者既往接受过放疗;平均肿瘤体积为2.7 cm3,中位边缘剂量为15 Gy。
主要发现
- 平均随访60.5个月(范围6-164个月);1年、5年、10年无进展生存率分别为74.9%、52.8%、39.1%;9个月、1年、5年总生存率分别为97.4%、94.6%、91.8%。
- 实体肿瘤控制率达69.2%,囊性增大记录于12.9%的病例;末次随访时57.7%的病例体积缩小,中位体积缩小33.3%。
- 52.4%的患者观察到临床改善;卡氏功能状态评分改善15例(45.5%),不变17例(51.5%),恶化1例(3%)。
- 治疗后36项简表健康调查各域平均分与健康意大利人群的评分无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: First-line therapy for low-grade gliomas (LGGs) is surgery, in some cases followed by radiotherapy and chemotherapy. Gamma Knife radiosurgery (GKRS) has gained more relevance in the management of these tumors. The aim of this study was to assess efficacy and safety of GKRS for treatment of LGGs. METHODS: Between 2001 and 2014, 42 treatments were performed on 39 patients harboring LGGs; 48% of patients underwent previous surgery, and 20.5% underwent previous radiotherapy. Mean tumor volume was 2.7 cm3, and median margin dose was 15 Gy. RESULTS: Mean follow-up was 60.5 months (range, 6-164 months). Actuarial progression-free survival was 74.9%, 52.8%, and 39.1% at 1 year, 5 years, and 10 years; actuarial overall survival was 97.4%, 94.6%, and 91.8% at 9 months, 1 year, and 5 years. Solid tumor control was achieved in 69.2% of patients, whereas cystic enlargement was recorded in 12.9% of cases. At last follow-up, volume reduction was recorded in 57.7% of cases, and median volume decreased by 33.3%. Clinical improvement was observed in 52.4% of patients. Karnofsky performance scale score was improved in 15 patients (45.5%), unchanged in 17 patients (51.5%), and worsened in 1 patient (3%). Mean posttreatment scores of 36-item short form health survey domains did not significantly differ from scores in a healthy Italian population. CONCLUSIONS: This study confirms safety and effectiveness of GKRS for LGGs in controlling tumor growth, relevantly improving patients' overall and progression-free survival. GKRS improved patients' functional performance and quality of life, optimizing social functioning and minimizing disease-related psychological impact.
引用
- Gagliardi F, Bailo M, Spina A, et al. Gamma Knife Radiosurgery for Low-Grade Gliomas: Clinical Results at Long-Term Follow-Up of Tumor Control and Patients' Quality of Life. World Neurosurg. 2017. PMID: 28216397. doi:10.1016/j.wneu.2017.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。